BlackRock HlthSc Op Svc
BlackRock HlthSc Op Svc (SHISX)
This investment vehicle aims to achieve long-term capital appreciation for its shareholders. It primarily allocates a minimum of 80% of its total assets to equities, predominantly common stock, of companies operating in the health sciences sector and associated industries. This encompasses businesses involved in areas such as healthcare equipment and supplies, service providers, biotechnology, and pharmaceuticals. A key strategy involves concentrating over 25% of its portfolio in these health sciences or related sectors. Furthermore, the fund may invest in companies situated in non-U.S. countries.
SHISX Mutual Fund Chart & Stats
- Previous Close
- $69.85
- Sub-Category
- Sector-Specific
- Total Liabilities
- $82.87M
- Last Dividend Ex-Date
- Jul 22, 2026
- Expense Ratio
- 1.16%
- Holding Count
- 121
- Brand
- Blackrock Funds
- Dividend Yield
- (13.58%)
- Category
- Equity
- Total Assets
- 6.46B
- Shares Outstanding
- N/A
- 52-Week Range
- $60.45 - $70.67
SHISX Mutual Fund News
AbbVie Crohn’s Disease Study Update Offers Limited Near-Term Stock Impact
Abbvie ($ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie’s official study, “A Post-marketing Non-interventional Study for Upadacitinib in Patients With Moderately to Severely Active Crohn’s Disease
SHISX Mutual Fund Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| LLYEli Lilly And Company | 11.92% |
| JNJJohnson & Johnson | 8.03% |
| MRKMerck & Company | 5.56% |
| ABBVAbbvie | 5.07% |
| TMOThermo Fisher Scientific | 4.41% |
| UNHUnitedhealth Group Inc. | 4.33% |
| GILDGilead Sciences | 4.09% |
| AMGNAmgen Inc | 3.98% |
| VRTXVertex Pharmaceuticals Inc. | 3.33% |
| ABTAbbott Laboratories | 2.74% |
| Total | 53.47% |
Recently Viewed
No data currently available






